Redefining Interventional Therapy for Severely Calcified Lesions

AVS is an early-stage medical device company that is focused on safely and effectively treating severely calcified arterial disease. AVS is the first company to develop pulsatile intravascular lithotripsy (PIVL), a therapy that is delivered through a balloon-based platform called the Pulse IVL System. It is designed to be the only minimally invasive technology that gently shatters calcium and opens the artery using a single device.

Our Journey

  • 2017

    Michigan logo

     

    • Company founded by clinical and engineering team from University of Michigan
    • Proof of concept developed

     

  • 2018

    A line drawing of a coin above a hand.

     

    • Grant support received from NIH/Cleveland Clinic and U of M Fast Forward Medical Innovation

     

  • 2019

    A line drawing of two hands encompassing a sheild.

     

    • Completion of successful animal study for safety
    • Performed early cadaver study with positive results
    • Patents filed with US Patents & Trademark Office

     

  • 2020

    Line art representing an iconic institution building.

     

    • Secured funding from visionary healthcare investment firm
    • Hired management team

     

  • 2021

    A line drawing of a set of interlocking gears.

     

    • Built peripheral product
    • Completed cadaver studies with positive results confirmed by Renu Virmani
    • TCT Shark Tank Innovation finalist

     

  • 2022

    A line drawing representing a doctor.

     

    • First patent granted
    • Successfully performed first in human cases
    • Initiated product development for coronary indication

     

 

 

CRF Shark Tank Logo

“We are proud to have been selected as a FINALIST in the CRF Shark Tank Innovation Competition”